Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Esophageal Squamous Cell Carcinoma × avelumab × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 11 Urinary Bladder Neoplasms 9 Neoplasms 8 Ovarian Neoplasms 6 Neoplasm Metastasis 6 Carcinoma, Renal Cell 5 Pancreatic Neoplasms 4 Carcinoma, Transitional Cell 4 Carcinoma, Merkel Cell 4 Breast Neoplasms 4 Lymphoma 3 Fallopian Tube Neoplasms 3 Triple Negative Breast Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Recurrence 2 Prostatic Neoplasms 2 Lung Neoplasms 2 Leukemia, Myeloid, Acute 2 Kidney Neoplasms 2 Kidney Diseases 2 Colorectal Neoplasms 2 Carcinoma, Ovarian Epithelial 2 Urothelial Cancer 1 Urologic Neoplasms 1 Urethral Neoplasms 1 Ureteral Neoplasms 1 Turcot syndrome 1 Stomach Neoplasms 1 Sezary Syndrome 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1

Interventions

Radiotherapy 10 Cisplatin 9 Paclitaxel 8 pembrolizumab 7 Fluorouracil 7 Oxaliplatin 6 Irinotecan 6 Cetuximab 5 tislelizumab 4 Docetaxel 4 Radiation 3 Leucovorin 3 Carboplatin 3 Capecitabine 3 Nivolumab 2 Neoadjuvant Therapy 2 Immunohistochemistry 2 Biopsy 2 10-propargyl-10-deazaaminopterin 2 tremelimumab 1 sitravatinib 1 sintilimab 1 regorafenib 1 pegylated granulocyte colony-stimulating factor, human 1 pegfilgrastim 1 oblimersen 1 durvalumab 1 cixutumumab 1 adavosertib 1 Taxes 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡